[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355781-105":59,"doc-detail-355781-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ran-s100a10-egfr-axis-facilitates-papillary-thyroid-cancer-metastasis-by-pi3kakt-signaling","RAN-S100A10-EGFR axis facilitates papillary thyroid cancer metastasis by PI3K/AKT signaling","","The study investigates how S100A10 drives papillary thyroid cancer (PTC) metastasis and clarifies the molecular mechanism involved. Single-cell RNA sequencing from public databases identifies S100A10 as a candidate biomarker linked to metastasis and prognosis. Expression is validated in tissues and cell lines using RT-qPCR and western blot, while protein interactions are assessed by mass spectrometry and co-immunoprecipitation. Functional assays and EMT readouts show that S100A10 activates PI3K/AKT signaling, enhances invasiveness, and forms a RAN-S100A10-EGFR regulatory axis, suggesting therapeutic targeting potential.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ran-s100a10-egfr-axis-facilitates-papillary-thyroid-cancer-metastasis-by-pi3kakt-signaling/355781/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ran-s100a10-egfr-axis-facilitates-papillary-thyroid-cancer-metastasis-by-pi3kakt-signaling/355781.png","ImageObject",300,407,{"name":92,"@type":93},"Pentious","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address in papillary thyroid cancer?","Question",{"text":112,"@type":113},"It focuses on the molecular mechanisms underlying lymph node and distant metastasis in papillary thyroid cancer, where the specific role of S100A10 is not well defined.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was S100A10 identified as related to PTC metastasis?",{"text":117,"@type":113},"Single-cell RNA sequencing data were analyzed to screen differentially expressed genes, and S100A10 emerged as a potential biomarker associated with PTC metastasis and prognosis.",{"name":119,"@type":110,"acceptedAnswer":120},"What signaling pathway and cellular process are linked to S100A10 in the results?",{"text":121,"@type":113},"S100A10 activates PI3K/AKT signaling and promotes EMT in PTC cells, increasing tumor invasiveness.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355781,1790993695,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374404730887,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nRAN-S100A10-EGFR axis facilitates papillary thyroid cancer metastasis by PI3K/AKT signaling  \nWenbin Song 1,6, Zhaoyi Liu 1,6, Cangchang Shi1,6, Guixin Wang 2,6, Long He1, Zhaohui Chen 2, Yingxi Li 3, Yue Yu 2, Ruoyu Jiang 1, Xiaoning Wang1, Ke Zhao 1, Ziyi Chen4, Yao Tian 1,2,5, Feng Qi 1 ✉, Yizeng Wang 1 ✉ and Xianghui He 1 ✉  \n© The Author(s) 2026  \n\n|  | Background: The incidence of thyroid cancer has been increasing in recent years, with papillary thyroid carcinoma (PTC) accounting for the majority of cases. Accumulating studies have demonstrated that S100A10 acts as an oncogene in the progression of various malignancies. However, the function and speciﬁc mechanisms of S100A10 in thyroid cancer remain poorly deﬁned. Methods: Single-cell RNA sequencing data of PTC from public databases were analyzed to screen differentially expressed genes (DEGs), among which S100A10 emerged as a potential biomarker associated with PTC metastasis and prognosis. The expression of S100A10 in tissues and cell lines were validated by RT-qPCR and western blot. Protein-protein interactions were conﬁrmed using mass spectrometry analysis and co-immunoprecipitation. The subcellular localization of the protein was determined by immunoﬂuorescence. Stable PTC cell lines overexpressing S100A10 were constructed and followed by transwell assays, woundhealing assays, and western blot for EMT capability detection. Results: S100A10 was found to play essential roles in tumor metastasis and was associated with unfavorable prognosis in patients with PTC. S100A10 was expressed higher in both PTC tissues and cells. Furthermore, both in vitro and in vivo experiments conﬁrmed that S100A10 activates the PI3K/AKT signaling and promotes EMT in PTC cells, enhancing the invasive capabilities of tumors. S100A10 could interact with both RAN and EGFR intracellularly, forming a RAN-S100A10-EGFR regulatory axis. Finally, several potential drugs targeting S100A10 were identiﬁed for further in-depth research. Conclusion: These ﬁndings clarify the role of S100A10 and RAN in PTC progression and highlight their |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| potential as therapeutic targets, linking EMT with PI3K/AKT signaling. |  |  |\n|  | Cell Death and Disease (2026)17:510; [https://doi.org/10.1038/s41419-026-08649-6](https://doi.org/10.1038/s41419-026-08649-6) |  |\n|  |  |  |\n\nINTRODUCTION  \nAccording to the GLOBOCAN 2020 Cancer Incidence and Mortality database by the International Agency for Research on Cancer (IARC), part of the World Health Organization (WHO), thyroid cancer ranks ninth in global cancer incidence rates. The global incidence of thyroid cancer has continued to rise over the past four decades [1] . Among all malignant thyroid neoplasms, papillary thyroid carcinoma (PTC) is the most prevalent welldifferentiated carcinoma, constituting approximately 80–85% of all thyroid cancers [2, 3] . While the majority of patients exhibit a favorable prognosis, a subset may encounter recurrence or distant metastasis during follow-up. Additionally, some may present with lateral cervical lymph node metastasis and distant metastasis at the time of initial diagnosis [4, 5] . This condition can lead to a reduced quality of life, a poorer prognosis, and increased treatment challenges [6] . Therefore, investigating the molecular mechanisms of lymph node metastasis in PTC is essential.  \nWith the advancement of sequencing technology, scholars are now able to observe cellular-level changes in cancer tissue through single-cell RNA sequencing (scRNA-seq) technology, which offers novel strategies for cancer diagnosis and treatment [7] . Single-cell technology is a valuable method for exploring the occurrence and progression of tumors [8] . While techniques such as microarray sequencing reﬂect expression","cbCailSp1GSndYvm","https://ap.wps.com/l/cbCailSp1GSndYvm","pdf",12597893,13,"English","# Introduction","[{\"question\":\"What problem does the study address in papillary thyroid cancer?\",\"answer\":\"It focuses on the molecular mechanisms underlying lymph node and distant metastasis in papillary thyroid cancer, where the specific role of S100A10 is not well defined.\"},{\"question\":\"How was S100A10 identified as related to PTC metastasis?\",\"answer\":\"Single-cell RNA sequencing data were analyzed to screen differentially expressed genes, and S100A10 emerged as a potential biomarker associated with PTC metastasis and prognosis.\"},{\"question\":\"What signaling pathway and cellular process are linked to S100A10 in the results?\",\"answer\":\"S100A10 activates PI3K/AKT signaling and promotes EMT in PTC cells, increasing tumor invasiveness.\"}]","RAN-S100A10-EGFR axis facilitates papillary thyroid cancer metastasis by PI3K/AKT signaling | PDF",1790120936,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c119e222025d1a342d96dd065896c659.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8e340c034e30971056f047ba4a57d455.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ed0159d4e700e9d85bed7b000d2443ac.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7c1ac1b144ac24fbfd72ee29405c1109.webp",980,1301]